Dynamic Bh3 Profiling Reveals Novel Therapeutic Strategies For The Treatment Of Double-Hit Lymphoma

BLOOD(2017)

Cited 2|Views28
No score
Abstract
Introduction: Double-hit lymphomas (DHL), a subset of diffuse large B-cell lymphoma (DLBCL) harboring both a MYC and BCL-2 or BCL-6 gene rearrangement, are associated with rapidly progressive disease that is often refractory to aggressive therapy. Given these poor outcomes, novel therapeutic strategies and drug combinations are desperately needed.
More
Translated text
Key words
dynamic bh3 profiling,novel therapeutic strategies,double-hit
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined